scPharmaceuticals Inc. — Director's Dealing 2021

Feb 18, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: scPharmaceuticals Inc. (SCPH)
CIK: 0001604950
Period of Report: 2021-02-16

Reporting Person: Abraham William Tober (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-02-16	Stock Option (right to buy)	$7.25	A	32600	Acquired	2031-02-16	Common Stock (32600)	Direct

Footnotes

F1: On February 16, 2021 the Reporting Person was granted an option to purchase 32,600 shares of common stock. 33% of the shares shall vest on February 16, 2022 and the remaining shall vest in equal monthly installments over the following 24 months.